[<sup>18</sup>F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality Issue

[<sup>18</sup>F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality Issue

Radiopharmaceuticals targeting the prostate-specific membrane antigen (PSMA) has become the gold standard for PET imaging of prostate cancer. [<sup>68</sup>Ga]Ga-PSMA-11 has been the forerunner but a [<sup>18</sup>F]F-PSMA ligand has been developed because of the intrinsic ad...

Full description

Bibliographic Details
Main Authors: Valentina Di Iorio, Stefano Boschi, Anna Sarnelli, Cristina Cuni, David Bianchini, Manuela Monti, Giancarlo Gorgoni, Giovanni Paganelli, Federica Matteucci, Carla Masini
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Pharmaceuticals
Subjects:
prostate cancer
PSMA
[<sup>18</sup>F]F-PSMA-1007
[<sup>18</sup>F]F<sup>-</sup>
quality assurance
PET Radiopharmacy
Online Access:https://www.mdpi.com/1424-8247/14/7/599

Internet

https://www.mdpi.com/1424-8247/14/7/599

Similar Items